$228 Million is the total value of DCF Advisers, LLC's 68 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 53.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $14,594,000 | -22.3% | 238,500 | -33.6% | 6.39% | -16.1% |
| ABBV | Sell | ABBVIE INC | $14,387,000 | +7.0% | 88,750 | -10.6% | 6.30% | +15.6% |
| MU | Sell | MICRON TECHNOLOGY INC | $13,047,000 | -21.1% | 167,500 | -5.6% | 5.71% | -14.8% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $10,267,000 | -5.5% | 14,700 | -14.5% | 4.50% | +2.1% |
| GDX | Sell | VANECK EFT TRUSTgold miners etf | $3,931,000 | +6.7% | 102,500 | -10.9% | 1.72% | +15.3% |
| INCY | Sell | INCYTE CORP | $3,614,000 | -29.7% | 45,500 | -35.0% | 1.58% | -24.0% |
| TPB | Sell | TURNING PT BRANDS INC | $3,526,000 | -16.6% | 103,676 | -7.4% | 1.54% | -10.0% |
| GM | Sell | GENERAL MTRS CO | $3,499,000 | -29.8% | 80,000 | -5.9% | 1.53% | -24.2% |
| ORCL | Sell | ORACLE CORP | $3,226,000 | -13.0% | 39,000 | -8.2% | 1.41% | -6.0% |
| LLY | Sell | LILLY ELI & CO | $2,964,000 | -4.6% | 10,350 | -8.0% | 1.30% | +3.0% |
| AOD | Sell | ABERDEEN TOTAL DYNAMIC DIVD | $2,470,000 | -6.7% | 257,000 | -0.8% | 1.08% | +0.8% |
| PFE | Sell | PFIZER INC | $2,407,000 | -37.3% | 46,500 | -28.5% | 1.05% | -32.3% |
| F | Sell | FORD MTR CO DEL | $2,080,000 | -40.7% | 123,000 | -27.1% | 0.91% | -35.9% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $1,725,000 | +28.0% | 189,565 | -1.3% | 0.76% | +38.2% |
| SLV | Sell | ISHARES SILVER TRishares | $1,030,000 | -29.1% | 45,000 | -33.3% | 0.45% | -23.4% |
| BIF | Sell | BOULDER GROWTH & INCOME FD I | $964,000 | -18.2% | 65,000 | -21.7% | 0.42% | -11.7% |
| EQ | Sell | EQUILLIUM INC | $522,000 | -26.3% | 165,663 | -11.7% | 0.23% | -20.2% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $494,000 | -8.3% | 150,000 | -6.2% | 0.22% | -1.4% |
| MU | Sell | MICRON TECHNOLOGY INCput | $467,000 | -49.9% | 6,000 | -40.0% | 0.20% | -45.8% |
| LCTX | Sell | LINEAGE CELL THERAPEUTICS IN | $82,000 | -60.6% | 53,000 | -37.6% | 0.04% | -57.1% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $81,000 | -80.9% | 15,000 | -52.1% | 0.04% | -79.7% |
| REGN | Exit | REGENERON PHARMACEUTICALScall | $0 | – | -200 | -100.0% | -0.05% | – |
| MTNB | Exit | MATINAS BIOPHARMA HLDGS INC | $0 | – | -154,500 | -100.0% | -0.06% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INC | $0 | – | -5,000 | -100.0% | -0.11% | – |
| VIAC | Exit | VIACOMCBS INCcl b | $0 | – | -11,100 | -100.0% | -0.14% | – |
| APTV | Exit | APTIV PLC | $0 | – | -2,250 | -100.0% | -0.15% | – |
| DISCA | Exit | DISCOVERY INC | $0 | – | -15,990 | -100.0% | -0.15% | – |
| FCX | Exit | FREEPORT-MCMORAN INCcl b | $0 | – | -10,000 | -100.0% | -0.17% | – |
| LIT | Exit | GLOBAL X FDSlithium btry etf | $0 | – | -5,000 | -100.0% | -0.17% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -5,000 | -100.0% | -0.19% | – |
| BOX | Exit | BOX INCcl a | $0 | – | -18,500 | -100.0% | -0.20% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -2,000 | -100.0% | -0.20% | – |
| XLP | Exit | SELECT SECTOR SPDR TRcall | $0 | – | -9,000 | -100.0% | -0.28% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -12,745 | -100.0% | -0.30% | – |
| NXPI | Exit | NXP SEMICONDUCTORS N V | $0 | – | -3,500 | -100.0% | -0.32% | – |
| VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -20,000 | -100.0% | -0.34% | – |
| MSFT | Exit | MICROSOFT CORP | $0 | – | -2,500 | -100.0% | -0.34% | – |
| INTC | Exit | INTEL CORP | $0 | – | -20,000 | -100.0% | -0.42% | – |
| MS | Exit | MORGAN STANLEY | $0 | – | -12,500 | -100.0% | -0.50% | – |
| HON | Exit | HONEYWELL INTL INCcall | $0 | – | -9,000 | -100.0% | -0.76% | – |
| ORCL | Exit | ORACLE CORPcall | $0 | – | -22,500 | -100.0% | -0.80% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -32,500 | -100.0% | -0.82% | – |
| VZ | Exit | VERIZON COMMUNICATIONS INC | $0 | – | -50,000 | -100.0% | -1.05% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -12,750 | -100.0% | -1.16% | – |
| VOO | Exit | VANGUARD INDEX FDSput | $0 | – | -65,000 | -100.0% | -11.51% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 16 | Q3 2023 | 10.2% |
| MICRON TECHNOLOGY INC | 16 | Q3 2023 | 6.7% |
| ALPHABET INC | 16 | Q3 2023 | 5.8% |
| ABBVIE INC | 16 | Q3 2023 | 7.9% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 5.5% |
| ARGENX SE | 16 | Q3 2023 | 6.4% |
| SPDR GOLD TRUST | 16 | Q3 2023 | 6.6% |
| XENCOR INC | 16 | Q3 2023 | 4.1% |
| BK OF AMERICA CORP | 16 | Q3 2023 | 5.4% |
| ORACLE CORP | 16 | Q3 2023 | 3.2% |
View DCF Advisers, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-15 |
View DCF Advisers, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.